Cracking the Code of Cellular Health: Dr. Vocadlo’s Pioneering Research
University of Alberta Assigns Full Suite of Patents to 48Hour Discovery as Revenue Exceeds $5 Million Triggering Key Milestone
Research Chair recieves $8 million over the next eight years to continue his work at the University of Alberta
Syantra Announces Liquid Biopsy Platform Breakthrough with Expanded Intellectual Property Portfolio; Partnership with Limmi to Accelerate AI-Powered RNA-Based Early Cancer Detection Liquid Biopsy Program
Alberta Virtual Care Coordinating Body (AVCCB)
Orano Med and 48Hour Discovery to Develop Innovative Peptide Receptor Radionuclide Therapy for Targeted Cancer Treatment
The Alberta Virtual Care Coordinating Body (AVCCB)
New process produces purer, safer pancreas stem cells for potential transplant
New statistical tool could mean clinical trials yield better information with fewer patients
48Hour Discovery Reveals New Insight into Cellular Regulation: Breakthrough Discovery for Controlling Cell Activity
